0001613377-18-000012.txt : 20180719
0001613377-18-000012.hdr.sgml : 20180719
20180719125032
ACCESSION NUMBER: 0001613377-18-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180718
FILED AS OF DATE: 20180719
DATE AS OF CHANGE: 20180719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PASCALE ADAM
CENTRAL INDEX KEY: 0001613377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-27072
FILM NUMBER: 18960083
MAIL ADDRESS:
STREET 1: 600 MAIN STREET
STREET 2: SUITE 2
CITY: RIVERTON
STATE: NJ
ZIP: 08077
FORMER NAME:
FORMER CONFORMED NAME: Pascale Adam
DATE OF NAME CHANGE: 20140710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC
CENTRAL INDEX KEY: 0000946644
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 520845822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 860 N. ORANGE AVENUE
STREET 2: SUITE B
CITY: ORLANDO
STATE: FL
ZIP: 32801
BUSINESS PHONE: 407-271-8516
MAIL ADDRESS:
STREET 1: 860 N. ORANGE AVENUE
STREET 2: SUITE B
CITY: ORLANDO
STATE: FL
ZIP: 32801
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-07-18
0
0000946644
HEMISPHERX BIOPHARMA INC
HEB
0001613377
PASCALE ADAM
600 MAIN STREET
SUITE 2
RIVERTON
NJ
08077
0
1
0
0
CFO
Options to buy Common Stock
0.31
2018-07-18
4
A
0
53763
0
A
2018-07-18
2028-07-18
Common Stock
53763
53763
D
This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.
Adam Pascale
2018-07-19